Sex as a Biological Variable Supplement - Preventing SARS-CoV-2 infection by targeting human type II transmembrane serine protease activity

性别作为生物变量补充剂 - 通过靶向人类 II 型跨膜丝氨酸蛋白酶活性预防 SARS-CoV-2 感染

• 批准号: 424692
• 负责人: Leduc Richard
• 金额: $ 3.64万
• 依托单位: Universit de Sherbrooke
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2020
• 资助国家: 加拿大
• 起止时间: 2020-04-01 至 2021-04-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=424692&lang=en
• 关键词: Host Protease; Protease Inhibitors; Serine Protease

The SARS-CoV-2 coronavirus causing COVID-19 has been declared a global emergency by the World Health Organization which has mobilized international scientists to collaborate in order to find therapies to counteract the virus's effects which can be devasta

世界卫生组织已宣布引起COVID-19的SARS-CoV-2冠状病毒为全球紧急情况，该组织已动员国际科学家合作，以找到对抗该病毒影响的疗法，该病毒的影响可能会被忽视。